Chinese cell therapy effective in small multiple myeloma trial

CHICAGO (Reuters) - A small trial conducted in China found that an experimental therapy using altered cells to recruit the body's immune system to attack cancer can induce remission in most patients with advanced multiple myeloma, a blood plasma cancer.